Romainių vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 441,816 | 414,888 | 440,356 | 394,917 | 381,585 | 327,454 | 278,858 | 163,926 |
| Profit before tax | 7,594 | -19,543 | 12,991 | 13,538 | 2,609 | -25,707 | - | - |
| Net profit | 7,287 | -19,543 | 12,654 | 12,929 | 2,491 | -25,707 | 57,795 | -65,961 |
| Equity | -30,905 | -50,448 | -37,814 | -24,885 | -22,393 | -48,100 | 9,695 | -55,839 |
| Liabilities | 233,802 | 238,233 | 213,503 | 208,268 | 209,470 | 203,628 | 104,921 | 56,260 |
| Non-current assets | 10,406 | 4,280 | 144 | 1,093 | 2,273 | 1,610 | 856 | 0 |
| Current assets | 192,491 | 183,505 | 175,545 | 182,290 | 184,804 | 153,918 | 113,760 | 421 |
| Total assets | 202,897 | 187,785 | 175,689 | 183,383 | 187,077 | 155,528 | 114,616 | 421 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 18,444 | 13,343 | 22,833 |
| Social insurance contributions | - | - | - | - | - | 23,739 | 17,126 | 13,919 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -0.6% | -6.1% | +6.1% | -10.3% | -3.4% | -14.2% | -14.8% | -41.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.6% | -10.4% | 7.2% | 7.1% | 1.3% | -16.5% | 50.4% | -15667.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | 596.1% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.6% | -4.7% | 2.9% | 3.3% | 0.7% | -7.9% | 20.7% | -40.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.7% | -4.7% | 3.0% | 3.4% | 0.7% | -7.9% | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | 10.8 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 19,140 | 20,744 | 24,352 | 22,354 | 23,362 | 24,107 | 27,429 | 25,437 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Romainių vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-11-16 | 2023-11-16 | 1652.11 |
| 2022-07-18 | 2022-07-20 | 13.65 |
| 2022-06-16 | 2022-06-20 | 42.49 |
Romainių vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-11-02 | 2025-11-02 | 45.45 |
| 2025-10-30 | 2025-11-01 | 3.41 |
| 2025-10-26 | 2025-10-29 | 291.92 |
| 2025-10-25 | 2025-10-25 | 0.92 |
| 2025-09-28 | 2025-10-24 | 1.12 |
| 2025-09-27 | 2025-09-27 | 0.24 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Romainiu vaistine, UAB (code 133920879) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, revenue fell to €163.9K from €278.9K in 2024 and €327.5K in 2023, reflecting a clear two-year decline. The company posted a net loss of €66.0K in 2025, after a net profit of €57.8K in 2024 and a loss of €25.7K in 2023. The 2025 profit margin was -40.2%, showing a sharp deterioration versus the prior year. The balance sheet also weakened: total assets dropped to €421 in 2025 from €114.6K in 2024, while liabilities stood at €56.3K and equity was negative at -€55.8K. In 2024, assets and equity were still positive, but the business remained highly volatile. Revenue per employee in 2025 was €27.3K, with profit per employee at -€11.0K. Overall, the latest year was marked by lower turnover, a significant loss, and a very weak balance-sheet position.